Scholarly Index
Antonio Lanzavecchia
Vir Biotechnology (Switzerland); 109,783 total citations; 460 total publications; best world rank #6
Vir Biotechnology (Switzerland)
109,783Total citations
460Total publications
153H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Biological Sciences | Lifetime | 590 | CH 13 | 99.93 |
| Immunology | Lifetime | 16 | CH 1 | 99.96 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 493 | CH 16 | 98.76 |
| T-cell and B-cell Immunology | Lifetime | 6 | CH 1 | 99.97 |
| Immunotherapy and Immune Responses | Lifetime | 10 | CH 1 | 99.97 |
| Immune Cell Function and Interaction | Lifetime | 14 | CH 1 | 99.97 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 82 | CH 2 | 99.78 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 159 | CH 3 | 99.28 |
| CAR-T cell therapy research | Lifetime | 216 | CH 5 | 99.25 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 185 | CH 2 | 98.99 |
| vaccines and immunoinformatics approaches | Lifetime | 82 | CH 4 | 98.82 |
| Immune Response and Inflammation | Lifetime | 506 | CH 14 | 98.73 |
| Chemokine receptors and signaling | Lifetime | 110 | CH 6 | 97.96 |